Daniel Verrill, MD
Interventional Pain Medicine · Kettering, OHNPI 1447543525
Payments from drug & device makers
What this record shows
The money is spread across several categories — speaking fees (42.5%), food and beverage and travel and lodging — rather than concentrated in one kind of arrangement. 7 manufacturers reported payments, led by Medtronic at 56.6% of the total. Reporting peaked in 2020 at $5,663 and has fallen 97.6% since, to $138 in 2025.
Across 239 payments — averaging $48.75 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Medtronic$7K
- Vertiflex, Inc.$2K
- Abbott$1K
- Relievant Medsystems, Inc.$1K
- Stimwave Technologies Incorporated$375
- Nevro Corp.$317
- plus $129 from 1 others
Across 10 payments — averaging $3776.50 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Medtronic$38K
What the payments were for
- Speaking & faculty fees$4,95042%
- Travel & lodging$2,10118%
- Food & beverage$4,60039%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Medtronic(2 entities) | 130 | $6,594 |
| Vertiflex, Inc. | 6 | $1,611 |
| Abbott | 81 | $1,436 |
| Relievant Medsystems, Inc. | 9 | $1,189 |
| Stimwave Technologies Incorporated | 4 | $375 |
| Nevro Corp. | 7 | $317 |
| Boston Scientific | 2 | $129 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- INTELLIS$1,933
- Intracept$1,924
- RESTORE$1,815
- Superion ISS$1,432
- Inflate FX$1,320
- Axium INS DRG IPG$477
- Proclaim Family of SCS IPGs$319
- Omnia$150
- KYPHON EXPRESS II KYPHOPAK TRAY$147
- S-Series SCS Leads$140
- Senza Spinal Cord Stimulation System$102
How this compares
$11,651 in reported general payments places this provider in the 65th percentile of 67 interventional pain medicine providers in Ohio.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Oxycodone Hcl | 58 | $268 |
| Cephalexin | 22 | $115 |
Paid to pharmacies, not to this prescriber.
Other interventional pain medicine in Kettering
- Gladstone McDowellColumbus$660K
- Humam AkbikFairfield$116K
- Sara NashiCincinnati$116K
- Jaudat MahmoodKent$97K
- Omar AliSpringfield$67K
- Dustin ReynoldsWesterville$61K
- James OttingToledo$47K
- Mark MalinowskiChillicothe$39K
- David WalegaColumbus$37K
- Ronald LinehanLancaster$26K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.